Rational thromboprophylaxis in medical inpatients: not quite there yet

John P Fletcher, Donald MacLellan, Harry Gibbs and Geoff Matthews
Med J Aust 2009; 190 (7): . || doi: 10.5694/j.1326-5377.2009.tb02467.x
Published online: 6 April 2009

To the Editor: In the 3 November 2008 issue of the Journal, Millar recommends against routine thromboprophylaxis in medical patients.1

  • John P Fletcher1
  • Donald MacLellan2
  • Harry Gibbs3
  • Geoff Matthews4

  • 1 Western Clinical School, Westmead Hospital, Sydney, NSW.
  • 2 NSW Health, Sydney, NSW.
  • 3 Princess Alexandra Hospital, Brisbane, QLD.
  • 4 Austin and Repatriation Medical Centre, Melbourne, VIC.


Competing interests:

All authors are members of the Australia and Zealand Working Party on the Management and Prevention of Venous Thromboembolism. John Fletcher has received speaker fees and travel assistance from Sanofi-Aventis and GlaxoSmithKline, and a speaker fee from Bayer Schering Pharma. Donald MacLellan has received non-directed educational grants from a number of pharmaceutical and non-pharmaceutical companies, including Sanofi-Aventis, to allay costs in the production of the Prevention of venous thromboembolism booklets. Harry Gibbs has received clinical trial funding, consultancy fees, honoraria and travel grants from a number of pharmaceutical and medical device companies, including Sanofi-Aventis, Pfizer and Boehringer Ingelheim. Geoff Matthews received travel assistance from Sanofi-Aventis.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.